Literature DB >> 12749063

Malignant hematological disorders in children with Wolf-Hirschhorn syndrome.

Anjali Sharathkumar1, Melanie Kirby, Melvin Freedman, Mohamed Abdelhaleem, David Chitayat, Ikuko E Teshima, Yigal Dror.   

Abstract

Wolf-Hirschhorn syndrome (WHS) is a rare chromosomal disorder attributable to a deletion at the short arm of chromosome 4. This syndrome is associated with characteristic facial appearance, multiple congenital abnormalities, mental retardation, feeding difficulties and failure to thrive. We report two girls with WHS who developed myelodysplastic syndrome (MDS). According to the "Category, Cytology, Cytogenetic (CCC)"classification of childhood MDS, patient 1 had refractory cytopenia with ring sideroblasts at the age of 6 years, while patient 2 had refractory cytopenia with dysplasia at the age of 5-1/2 years. Patient 1 progressed to refractory cytopenia with excess blasts within a year, while patient 2 progressed to acute lymphoblastic leukemia within 1 month of presentation. It is possible that allelic loss of a tumor suppressor gene such as WHSC1 and/or FGFR3 from the deleted segment 4p16.3 plays a critical role in the process of malignant transformation. To our knowledge, this is the first report of severe hematological complications like MDS and leukemia in children with WHS and may be an important genetic model for understanding malignant hematological transformation. This report also underscores the importance of evaluating children with WHS for hematopoietic dysfunction. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12749063     DOI: 10.1002/ajmg.a.20080

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice.

Authors:  Catarina Catela; Daniel Bilbao-Cortes; Esfir Slonimsky; Paschalis Kratsios; Nadia Rosenthal; Pascal Te Welscher
Journal:  Dis Model Mech       Date:  2009-04-21       Impact factor: 5.758

2.  Inflammatory myofibroblastic bladder tumor in a patient with wolf-hirschhorn syndrome.

Authors:  Antonio Marte; Paolo Indolfi; Carmine Ficociello; Daniela Russo; Matilde Oreste; Gaetano Bottigliero; Giovanna Gualdiero; Ciro Barone; Elena Vigliar; Cristiana Indolfi; Fiorina Casale
Journal:  Case Rep Urol       Date:  2013-08-18

3.  Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ-stimulated antitumor immunity.

Authors:  Jiale Ren; Ni Li; Siyu Pei; Yannan Lian; Li Li; Yuchong Peng; Qiuli Liu; Jiacheng Guo; Xuege Wang; Ying Han; Guoying Zhang; Hanling Wang; Yaqi Li; Jun Jiang; Qintong Li; Minjia Tan; Junjie Peng; Guohong Hu; Yichuan Xiao; Xiong Li; Moubin Lin; Jun Qin
Journal:  J Clin Invest       Date:  2022-04-15       Impact factor: 19.456

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.